The pharmaceutical sector is changing quickly because of changes in medicine, regulatory compliance, and the always-rising demand for safe and effective drugs worldwide. In this regard, a specialization area known as Non-Beta Lactam Third Party Manufacturing has emerged. It is a unique service that assists companies in enhancing their product offerings while also reducing production costs.
What is a Non-Beta Lactam Product?
Non-beta lactam drugs are drugs that ensure that patients who are allergic to beta-lactam antibiotics can access treatment because these antibiotics do not contain a beta-lactam ring structure. These include a diverse range of products such as:
- Anti-inflammatory drugs
- Anti-allergy medications
- Pain relievers
- Anti-fungal treatments
- Gastrointestinal medications
Third party manufacturing of non-beta Lactum products
Third Party Manufacturing or contract manufacturing is a facility that allows pharmaceutical firms to persist without having the in-house capacity to produce certain products. Such a business model is exemplified by Philanto Wellness, which can provide efficient and high-quality manufacturing solutions while also being completely compliant with regulations.
Philanto Wellness, which has its headquarters in Dera Bassi, Punjab, offers a wide selection of non-beta lactam products including tablets, capsules, syrups and ointments. Philanto Challenges Bulk Manufacturing with a Wide Portfolio
Benefits of Non-Beta Lactam Third Party Manufacturing
Cost Efficiency
Third party manufacturing negates the need to maintain any physical space for production and the expenditures that go with it.
Scalability
Philanto Wellness and similar manufacturers can produce large quantities which allows pharmaceutical companies to be more efficient and expand their production without a hassle.
Expertise and Quality
Third party manufacturers have a sound knowledge of the best practices within the industry and are also ISO 9001:2015 certified, thus instilling confidence in the quality of the output.
Regulatory Compliances
Companies work to meet the strict third-party manufacturer’s requirements to meet international regulatory standards.
Diverse Portfolio
Using a manufacturer like Philanto provides opportunities for companies to manufacture a portfolio of non-beta lactam drugs at no extra costs.
Non-Beta Lactam Products Offered by Philanto Wellness
Philanto Wellness has substantial opportunities in batch processes such as non-beta lactam and has a wide portfolio that incorporates the following
- Tablets: Aceclofenac, Paracetamol combinations, inflammatories and others
- Capsules: Pantoprazole, Rabeprazole, and probiotics.
- Syrups: Antiallergy, Pediatric suspension, Digestive health syrups.
- Ointments: Anti-fungal ointments and other topical dermatological.
Our non-beta Lactum Third Party Manufacturing Approval List
| Sr. No. | Composition | Type |
|---|---|---|
| 1 | Aceclofenac 100 mg & Thiocolchicoside 4 mg Tab. | Film Coated |
| 2 | Aceclofenac 100 mg & Thiocolchicoside 8 mg Tab. | Film Coated |
| 3 | Aceclofenac 100 mg + Paracetamol 325 mg + Trypsin Chymotrypsin 150,000 IU Tab. | Not Specified |
| 4 | Aceclofenac 100 mg + Paracetamol 325 mg + Trypsin Chymotrypsin 50,000 IU Tab. | Not Specified |
| 5 | Aceclofenac 100 mg + Paracetamol 325 mg + Trypsin Chymotrypsin 75,000 IU Tab. | Not Specified |
| 6 | Aceclofenac 100 mg + Paracetamol 325 mg & Serratiopeptidase 10 mg Tab. | Film Coated |
| 7 | Aceclofenac 100 mg + Paracetamol 325 mg & Serratiopeptidase 15 mg Tab. | Film Coated |
| 8 | Aceclofenac 100 mg + Paracetamol 325 mg Tab. | Uncoated |
| 9 | Aceclofenac 100 mg + Paracetamol 325 mg Tab. | Film Coated |
| 10 | Aceclofenac 100 mg & Tizanidine 2 mg Tab. | Film Coated |
| 11 | Aceclofenac 100 mg + Paracetamol 325 mg & Chlorzoxazone 500 mg Tab. | Uncoated |
| 12 | Aceclofenac 100 mg + Paracetamol 325 mg & Chlorzoxazone 250 mg Tab. | Not Specified |
| 13 | Aceclofenac 100 mg Tab. | Film Coated |
| 14 | Aceclofenac Sustained Release 200 mg Tab. | Film Coated |
| 15 | Aceclofenac 100 mg + Paracetamol 325 mg + Trypsin Chymotrypsin 1 Lac AU Tab. | Film Coated |
| 16 | Aceclofenac 100 mg + Paracetamol 325 mg + Trypsin Chymotrypsin 50,000 AU Tab. | Film Coated |
| 17 | Aceclofenac 100 mg + Paracetamol 325 mg + Thiocolchicoside 4 mg Tab. | Film Coated |
| 18 | Aceclofenac 200 mg & Pregabalin 75 mg Tab. | Enteric Coated |
| 19 | Aceclofenac 100 mg + Paracetamol 325 mg + Chlorzoxazone 500 mg Tab. | Film Coated |
| 20 | Diclofenac 50 mg + Paracetamol 325 mg + Trypsin Chymotrypsin 50,000 AU Tab. | Film Coated |
| 21 | Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU Tab. | Not Specified |
| 22 | Diclofenac Potassium 50 mg + Paracetamol 325 mg Tab. | Uncoated |
| 23 | Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg & Magnesium Trisilicate 100 mg Tab. | Uncoated |
| 24 | Diclofenac Potassium 50 mg + Paracetamol 325 mg & Serratiopeptidase 10 mg Tab. | Film Coated |
| 25 | Diclofenac Potassium 50 mg + Paracetamol 325 mg & Chlorzoxazone 250 mg Tab. | Uncoated |
| 26 | Diclofenac Potassium 50 mg + Paracetamol 325 mg & Chlorzoxazone 500 mg Tab. | Uncoated |
| 27 | Diclofenac Potassium 50 mg + Acetaminophen 325 mg + Chlorzoxazone 250 mg Tab. | Uncoated |
| 28 | Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg Tab. | Film Coated |
| 29 | Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Tab. | Film Coated |
| 30 | Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 15 mg Tab. | Film Coated |
| 31 | Diclofenac Sodium 50 mg + Paracetamol 325 mg Tab. | Uncoated |
| 32 | Diclofenac Sodium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg & Magnesium Trisilicate 100 mg Tab. | Uncoated |
| 33 | Nimesulide (In Beta-Cyclodextrin BP) 100 mg Tab. | Uncoated |
| 34 | Nimesulide 100 mg + Paracetamol 325 mg Tab. | Uncoated |
| 35 | Nimesulide 100 mg + Paracetamol 325 mg + Serratiopeptidase 15 mg Tab. | Film Coated |
| 36 | Nimesulide 100 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Tab. | Uncoated |
| 37 | Nimesulide 100 mg + Paracetamol 325 mg + Chlorzoxazone 500 mg Tab. | Uncoated |
| 38 | Nimesulide 100 mg + Phenylephrine HCL 10 mg + Dihydrochloride 5 mg + Caffeine 30 mg Tab. | Not Specified |
| 39 | Paracetamol 325 mg + Dexketoprofen Trometamol 25 mg Tab. | Film Coated |
| 40 | Paracetamol 325 mg + Caffeine 50 mg Tab. | Uncoated |
| 41 | Paracetamol 325 mg + Etodolac 150 mg Tab. | Film Coated |
| 42 | Paracetamol 325 mg + Etodolac 200 mg Tab. | Film Coated |
| 43 | Paracetamol 325 mg + Etodolac 300 mg Tab. | Film Coated |
| 44 | Paracetamol 325 mg + Dexibuprofen 200 mg Tab. | Uncoated |
| 45 | Paracetamol 325 mg + Dexibuprofen 300 mg Tab. | Uncoated |
| 46 | Paracetamol 325 mg + Eperisone Hydrochloride 50 mg Tab. | Uncoated |
| 47 | Paracetamol 325 mg + Ibuprofen 400 mg Tab. | Uncoated |
| 48 | Paracetamol 325 mg + Lornoxicam 8 mg Tab. | Not Specified |
| 49 | Paracetamol 325 mg + Dexketoprofen Trometamol 12.5 mg Tab. | Film Coated |
What is Special about Philanto Wellness?
- 2000+ Product Range: With a large range of products, they address growing customer diversity.
- State-of-the-Art Facilities: Modern plants designed for both volume and accuracy.
- Customized Solutions: Tailormade packaging or branding of the product to meet the needs of the client.
- Quick Delivery: Process improvement means production and shipping are done in the required timeframe.
Non-beta lactam drug market demand is ever-growing owing to escalating public health concerns coupled with increased beta-lactam antibiotic resistance. Companies of the nature of Philanto Wellness with an emphasis on innovative thinking, quality and scalable services are best positioned to exploit this market in both domestic and export markets.
Wider Global Outreach
With the increase of health-related issues and growing tolerance to beta-lactams, the need for non-beta lactam drugs keeps increasing in the market. The demand for licensing of such patented products is expected to be high in both the local and global markets for companies such as Philanto Wellness, which has an emphasis on quality, scalability and innovation.
Conclusion
Non-beta lactam contract manufacturing of pharmaceutical products provides an excellent opportunity for pharmaceutical companies for diversify of its capability and cost reduction as well as focus their efforts on its core business. Engaging with such well-established companies as Philanto Wellness guarantees quality products, shorter timelines for market penetration, and perpetual growth.
For more information, visit Philanto Wellness or get in touch with them at info@philantowellness.com.
Utilizing the resources of highly specialized manufacturers enables pharmaceutical companies not only to adapt to the changing environments of healthcare needs but also to be able to deliver affordable and effective services to the market.
